S511-3501 Screening compound: 4-[2-(4-methylpiperidin-1-yl)-2-oxoethyl]-N-(propan-2-yl)-1-oxa-9-azaspiro[5.5]undecane-9-carboxamide

S511-3501 Screening compound: 4-[2-(4-methylpiperidin-1-yl)-2-oxoethyl]-N-(propan-2-yl)-1-oxa-9-azaspiro[5.5]undecane-9-carboxamide
S511-3501 Screening compound: 4-[2-(4-methylpiperidin-1-yl)-2-oxoethyl]-N-(propan-2-yl)-1-oxa-9-azaspiro[5.5]undecane-9-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S511-3501
4-[2-(4-methylpiperidin-1-yl)-2-oxoethyl]-N-(propan-2-yl)-1-oxa-9-azaspiro[5.5]undecane-9-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S511-3501

Molecular Formula

C21H37N3O3 (C21 H37 N3 O3)

Compound Name

4-[2-(4-methylpiperidin-1-yl)-2-oxoethyl]-N-(propan-2-yl)-1-oxa-9-azaspiro[5.5]undecane-9-carboxamide

IUPAC name

4-[2-(4-methylpiperidin-1-yl)-2-oxoethyl]-N-(propan-2-yl)-1-oxa-9-azaspiro[5.5]undecane-9-carboxamide

SMILES

CC(C)NC(N(CC1)CCC11OCCC(CC(N2CCC(C)CC2)=O)C1)=O

InChI

InChI=1S/C21H37N3O3/c1-16(2)22-20(26)24-11-7-21(8-12-24)15-18(6-13-27-21)14-19(25)23-9-4-17(3)5-10-23/h16-18H,4-15H2,1-3H3,(H,22,26)/t18-/m0/s1

InChI Key

HZVFCQKRBYMNPR-SFHVURJKSA-N

MDL Number (MFCD)

MFCD31981055

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

379.54

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.538

Distribution Coefficient, logD

2.538

Water Solubility, LogSw

-2.61

Polar Surface Area

48.998

Acid Dissociation Constant (pKa)

16.85

Base Dissociation Constant (pKb)

2.87

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

90.48

S511-3501 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

3D-Pharmacophore Based Diversity Library (49813 compounds)

CNS MPO Library (28609 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Mimetics
  • Cyclic compounds
  • Mimetics
  • Cyclic compounds
Therapeutical areas:
  • Nervous system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators

References: we are preparing a list of scientific research reports with S511-3501 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S511-3501?
Check Price and Availability of S511-3501, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S511-3501 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S511-3501
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S511-3501
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S511-3501 available by request